首页> 外国专利> PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS OF PANIC AND ANXIETY USING BETA ADRENERGIC RECEPTOR ANTAGONIST AND MUSCARINIC RECEPTOR ANTAGONIST COMBINATIONS

PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS OF PANIC AND ANXIETY USING BETA ADRENERGIC RECEPTOR ANTAGONIST AND MUSCARINIC RECEPTOR ANTAGONIST COMBINATIONS

机译:β-肾上腺素能受体拮抗剂和肌肉受体拮抗药组合治疗药物性成分和方法,用于治疗头痛和焦虑症

摘要

The present invention is focused primarily toward pro re nata ("as needed") treatments for the symptoms of panic and anxiety. The present invention encompasses pharmaceutical compositions as combination therapies containing at least one beta adrenergic receptor antagonist and at least one muscarinic receptor antagonist. The invention provides a method for treating panic attack, panic disorder, anxiety, or an anxiety disorder comprising administering a pharmaceutical composition consisting essentially of a beta adrenergic receptor antagonist drug and an antiemetic muscarinic receptor antagonist drug in a therapeutically effective amount to stop or reduce the symptoms of anxiety or panic. The pharmaceutical compositions are administered as treatments immediately in advance of, at the onset of, or during an anxiety or panic episode.
机译:本发明主要针对惊恐和焦虑症状的治疗。本发明包括作为组合疗法的药物组合物,其包含至少一种β肾上腺素能受体拮抗剂和至少一种毒蕈碱受体拮抗剂。本发明提供了一种用于治疗惊恐发作,惊恐症,焦虑症或焦虑症的方法,该方法包括施用治疗有效量的基本上由β肾上腺素能受体拮抗剂药物和止吐毒蕈碱受体拮抗剂药物组成的药物组合物,以终止或减少该疾病。焦虑或惊慌的症状。药物组合物在焦虑或惊恐发作之前,发作或发作期间立即作为治疗剂施用。

著录项

  • 公开/公告号WO2016014117A1

    专利类型

  • 公开/公告日2016-01-28

    原文格式PDF

  • 申请/专利权人 DOOLEY THOMAS P.;

    申请/专利号WO2015US14657

  • 发明设计人 DOOLEY THOMAS P.;

    申请日2015-02-05

  • 分类号A61K31/138;A61K31/46;A61P25;

  • 国家 WO

  • 入库时间 2022-08-21 14:19:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号